Delivery Order SPE2DB20D2104-SPE2DB26FMAAQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,266.43 to AmerisourceBergen Drug Corp for the supply of Nexlizet 180-10 mg tablets (30-unit package) on August 5, 2025, with completion targeted for August 6, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed at the contractor's location in Conshohocken, Pennsylvania. As a child contract action under AmerisourceBergen's larger contract vehicle, this delivery order fulfills...
- The Defense Logistics Agency awarded a delivery order valued at $2,294.61 to AmerisourceBergen Drug Corp for Nexlizet 180-10 mg tablets (30-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger procurement vehicle supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,216.50, is non-competitive and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The award represents a single pharmaceutical product delivery under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,402.40 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,001.00, is scheduled for completion by June 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the company's competitive...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for NEXLIZET 180-10 MG tablets in 30-count units, valued at $2,205.61. This firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office division. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Nexlizet 180-10 mg tablets in packages of 30 units, with a contract ceiling value of $3,192.92. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 4, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.98 to AmerisourceBergen Drug Corp for NEXLIZET 180-10 MG tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitive award, which did not utilize a set-aside designation, represents a firm fixed-price transaction for pharmaceutical delivery to support federal medical procurement needs. The order is being fulfilled from AmerisourceBergen's Corporate Office location in...
- This delivery order, awarded on August 28, 2025, covers the supply of Nexlizet 180-10 mg tablets in quantities of 30 units to support the Defense Department's medical supply chain. Valued at $1,201.20 under a firm fixed-price contract type, the order was awarded without set-aside designation to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The place of performance is located at the vendor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,946.29 to AmerisourceBergen Drug Corp for Nexlizet 180-10 mg tablets (30-count unit of use packaging) with an ultimate completion date of August 20, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The order represents...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMAAQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,893.49 to AmerisourceBergen Drug Corp for the supply of Nexlizet 180-10 mg tablets (30-count units) with an ultimate completion date of October 15, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on October 14, 2025, with performance to be completed at the vendor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle functions as a comprehensive global pharmaceutical support mechanism, enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 10/14/25 |